References

1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364(9442): 1343-1360. Review.

2. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: A huge review. Am J Epidemiol 2000;151: 839-844.

3. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci 2006;27(4):204-210.

4. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103(11):4023-4027.

5. National Institutes of Health. The Management of Sickle Cell Disease. NIH Pub. No. 02-2117. Bethesda, MD, Division of Blood Diseases and Resources, Public Health Service, U.S. Department of Health and Human Services, June 2002:1-88.

6. World Health Organization Fifty-Ninth World Health Assembly 2006. Available at http://www.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf.

7. Lanzkowsky P. Manual of Pediatric Hematology and Oncology, 4th ed. New York: Churchill Livingstone, 2005:160.

8. Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2000;2000:2-17.

9. Sickle Cell Disease Care Consortium. Sickle Cell Disease in Children and Adolescents: Diagnosis, Guidelines for Comprehensive Care, and Care Paths and Protocols for Management of Acute and Chronic Complications, November 2001. ht-tp://www. scinfo.org/Protocol-2002.PDF.

10. American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedule—United States, 2009. Pediatrics 2009;123:189-190.

11. Committee on Infectious Diseases, American Academy of Pediatrics. Policy Statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-366.

12. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 2003;143:438-444.

13. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330(23):1639-1644.

14. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:83-89.

15. Advisory Committee on Immunization Practices, CDC. Preventing pneumococcal disease among infants and young children. Morb Mortal Wkly Rep 2000;49:1-38.

16. Falletta JM, Woods RM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127: 685-690.

17. Riddington C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumo-coccal infections in children with sickle cell disease. Cochrane Database 2002;(3):CD003427.

18. Kennedy TS, Fung EB, Kawchak DA, et al. Red blood cell folate and serum B12 status in children with sickle cell disease. J Pediatr Hematol Oncol 2001;23:165-169.

19. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.

20. Steinberg MH, Bartin F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-1651.

21. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999;94(5):1550-1554.

22. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematological efficacy of hydroxyurea at maximal tolerated dose in children with sickle cell disease. Blood 2004;103:2039-2045.

23. Hankins JS Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood 2005;106:2269-2275.

24. Wilson S. Acute leukemia in a patient with sickle cell anemia treated with hydroxyurea (letter). Ann Intern Med 2000;133:925-926.

TM TM

25. Hydroxyurea monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, inc.; 2008; September 29, 2008.

26. Deferoxamine monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, September 29, 2008.

27. Deferasirox monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, September 29, 2008.

28. Decitabine monograph. Lexi-Comp Online , Lexi-Drugs Online , Hudson,

Ohio: Lexi-Comp, September 29, 2008.

29. Folic acid monograph. Lexi-Comp Online , Lexi-Drugs Online , Hudson, Ohio:

Lexi-Comp, September 29, 2008.

30. Aronoff GR, Bennett WM, Berns JS, et al., eds. Drug Prescribing in Renal Failure, 15th ed. Philadelphia: American College of Physicians; 2007.

31. Koshy M, Dorn L, Bressler L, et al. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood 2000;248:378-381.

32. Porter J, Vinchinsky E, Rose C, et al. A Phase II study with ICL670 (Exjade), a once-daily oral iron chelator, in patients with various transfusion dependent anemias and iron overload (abstract). Blood 2004;104:3193.

33. Piga A, Galanello R, Foschini ML, et al. Once-daily treatment with the oral iron chelator ICL670 (Exjade): results of a Phase II study in pediatric patients with A-thalassemia major (abstract). Blood 2004;104:3614.

Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther 2003;3: 1215-1224.

Walters MC. Novel therapeutic approaches in sickle cell disease: Stem cell transplantation for sickle cell disease: How and when to intervene? Hematology Am Soc Hematol Educ Program 2002;22-29.

Adams RJ, Mckie VC, Bramilla D, Carl E, Gallagher D, Nichols FT, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110-129.

Vichinsky E. Novel therapeutic approaches in sickle cell disease: Understanding the pathophysiology and treatment of pulmonary injury in sickle cell disease. Hematology Am Soc Hematol Edu Program 2002;16-22.

Knight-Madden J, Hambleton I. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2003;3:CD003733.

Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-2568.

Mantadakis E, Ewalt DH, Cavender JD et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000;95:78-82.

Shantha TR, Finnerty DP, Rodriguez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989;1427-1429.

Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol 1994:151:878-879.

Owusu-Ofori S, Riddington C. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database of Systematic Reviews 2002;(4):CD003425.

AAP Committee on Drugs. APAP Toxicity in children. Peds 2001;108(1):1020-1024.

Jacob E, Miaskowski C, Savedra M, et al. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol 2003;25:307-311.

Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002;347(14):1094.

Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs 2003;5:229-238.

48. Yale SH. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician 2000;61:1349-1356, 1363-1364.

49. Maxwell LG, Kaufmann SC, Bitzer S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: A double-blind, prospective, randomized, controlled study. Anesth Analg 2005;100:953-958.

SECTION 15 DISEASES OF INFECTIOUS

ORIGIN

Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment